Clinical characteristics of the study cohort.

<p>Clinical characteristics of the study cohort.</p

Pharmacological thromboprophylaxis and its impact on venous thromboembolism following total knee and hip arthroplasty in Korea: A nationwide population-based study - Fig 1

<p><b>Annual trends of the rates of (A) pharmacological prophylaxis and (B)</b> ≥ <b>10 days of pharmacological prophylaxis in patients who underwent TKA or THA between 2009 and 2013.</b> Abbreviations: TKA, total knee arthroplasty; THA, total hip arthroplasty; APC, annual percentage change</p

The incidence of venous thromboembolism within 3 months of TKA/THA between 2009 and 2013.

<p>The incidence of venous thromboembolism within 3 months of TKA/THA between 2009 and 2013.</p

Incidence of venous thromboembolism based on the pharmacological thromboprophylaxis status.

<p>Incidence of venous thromboembolism based on the pharmacological thromboprophylaxis status.</p

Incidence of venous thromboembolism based on the length of pharmacological thromboprophylaxis.

<p>Incidence of venous thromboembolism based on the length of pharmacological thromboprophylaxis.</p

Red blood cell transfusions based on the pharmacological agents used.

<p>Red blood cell transfusions based on the pharmacological agents used.</p

Univariate and multivariate analyses to identify independent risk factors for venous thromboembolism development in the study cohort.

<p>Univariate and multivariate analyses to identify independent risk factors for venous thromboembolism development in the study cohort.</p

Overall flow of analyses.

<p>Overall flow of analyses.</p

Percentage of all VTE, DVT, and PE subjects who underwent procedures in each calendar year.

<p>Percentage of all VTE, DVT, and PE subjects who underwent procedures in each calendar year.</p

Pattern of prescription of anticoagulants during the study period.

<p>Pattern of prescription of anticoagulants during the study period.</p